Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome

DNA Repair

Volumn 2, Issue 5, 2003, Pages 593-608

  Garibyan, Lilit ^a   Huang, Tiffany ^a   Kim, Mandy ^a   Wolff, Erika ^a   Nguyen, Anh ^a   Nguyen, Theresa ^a   Diep, Amy ^a   Hu, Kaibin ^a   Iverson, Ayuko ^a   Yang, Hanjing ^a   Miller, Jeffrey H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Escherichia coli; Mutagenesis; Mutation detection; Mutators; Rifampicin resistance

Indexed keywords

2 AMINOPURINE; AZACITIDINE; CISPLATIN; MESYLIC ACID ETHYL ESTER; MUTAGENIC AGENT; OLIGONUCLEOTIDE; RIFAMPICIN;

ARTICLE; BACTERIAL CHROMOSOME; BASE PAIRING; BINDING SITE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE; GENE MUTATION; GENE SEQUENCE; MISMATCH REPAIR; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; ULTRAVIOLET RADIATION;

2-AMINOPURINE; ADENOSINE TRIPHOSPHATASES; ANTIBIOTICS, ANTITUBERCULAR; AZACITIDINE; BACTERIAL PROTEINS; BINDING, COMPETITIVE; CHROMOSOMES; CISPLATIN; CROSS-LINKING REAGENTS; DNA REPAIR; DNA-BINDING PROTEINS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; ETHYL METHANESULFONATE; MUTATION; MUTS DNA MISMATCH-BINDING PROTEIN; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; PYROPHOSPHATASES; RIFAMPIN; TEMPERATURE; ULTRAVIOLET RAYS;

ESCHERICHIA COLI;

EID: 0037435421     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-7864(03)00024-7     Document Type: Article

References (69)

1. Benzer S. On the topography of the genetic fine structure. Proc. Natl. Acad. Sci. U.S.A. 47:1961;403-415.
2. Benzer S., Freese E. Induction of specific mutations with 5-bromouracil. Proc. Natl. Acad. Sci. U.S.A. 44:1958;112-119.
3. Demerec M., Bertani G., Flint J. A survey of chemicals for mutagenesis action on E. coli. Am. Nat. 85:1951;119-136.
4. Bridges B.A. Simple bacterial systems for detecting mutagenic agents. Lab. Practices. 21:1972;413-419.
5. Yanofsky C., Ito J., Horn V. Amino acid replacements and the genetic code. Gold Spring Harbor Symp. Quant. Biol. 31:1966;151-162.
6. Ames B.N., Lee F.D., Durston W.E. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc. Natl. Acad. Sci. U.S.A. 70:1973;782-786.
7. Prakash L., Sherman F. Mutagenic specificity: reversion of iso-1-cytochrome c mutants of yeast. J. Mol. Biol. 79:1973;65-82.
8. Coulondre C., Miller J.H. Genetic studies of the lac repressor. IV. Mutagenic specificity in the lacl gene of Escherichia coli. J. Mol. Biol. 117:1977;577-606.
9. Cupples C., Miller J.H. A set of lacZ mutations in Eschereichia coli allows rapid detection of each o the six base substitutions. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5345-5349.
10. Coulondre C., Miller J.H., Farabaugh P.J., Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature. 274:1978;775-780.
11. Farabaugh P.J., Schmeissner U., Hofer M., Miller J.H. Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacl gene of Escherichia coli. J. Mol. Biol. 126:1978;847-863.
12. Schaaper R.M., Dunn R.L. Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. Proc. Natl. Acad. Sci. U.S.A. 84:1987;6220-6224.
13. LeClerc J.E., Istock N.L. Specificity of UV mutagenesis in the lac promoter of M13lac hybrid phage DNA. Nature. 297:1982;596-598.
14. Jackson A.L., Chen R., Loeb L.A. Induction of microsatellite instability by oxidative damage. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12468-12473.
15. Cairns J., Overbaugh J., Miller S. The origin of mutants. Nature. 335:1988;142-145.
16. Cairns J., Foster P.L. Adaptive reversion of a frameshift mutation in Echerichia coli. Genetics. 128:1991;670-695.
17. Rosenberg S.M. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2:2001;504-515.
18. Hendrickson H., Slechta E.S., Bergthorsson U., Andersson D.I., Roth J.R. Amplification-mutagenesis: evidence that directed adaptive mutation and general hypermutability result from growth with a selected gene amplification. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2164-2169.
19. Ovchinnikov Y.A., Monastyrskaya G.S., Guriev S.O., Kalinina N.F., Sverdlov E.D., Grageroc A.I., Bass I.A., Kiver I.F., Moiseyeva E.P., Igumnov V.N., Mindlin S.Z., Nimiforoc V.G., Khesin R.B. RNA polymerase rifampicin resistance mutations in Escherichia coli. Sequence changes and dominance. Mol. Gen. Genet. 190:1983;344-348.
20. Jin D.J., Gross C.A. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:1988;45-58.
21. Severinov K., Soushko M., Goldfarb A., Nikiforow V. Rifampicin region revisited. J. Biol. Chem. 268:1993;14820-14825.
22. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S.A. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 104:2001;901-912.
23. Rangarajan S., Gudmundsson G., Qiu Z., Foster P.L., Goodman M.F. Escherichia coli DNA polymerase II catalyzes chromosomal and episomal DNA synthesis in vivo. Proc. Natl. Acad. Sci. U.S.A. 94:1997;946-951.
24. Reynolds M.G. Compensatory evolution in rifampicin-resistant Escherichia coli. Genetics. 156:2000;1471-1481.
25. Musser J.M. Antimicrobial resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:1995;496-514.
26. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., Matter L., Schopfer K., Bodmer T. Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet. 341:1993;647-650.
27. Karunakaran P., Davies J. Genetic antagonism and hypermutability in Mycobacterium smegmatis. J. Bacteriol. 182:2000;3331-3335.
28. Cambau E., Bonnafous P., Perani E., Sougakoff W., Ji B., Jarlier V. Molecular detection of rifampicin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. Clin. Infect. Dis. 34:2002;39-45.
29. Klein J.L., Brown T.J., French G.L. Rifamin resistance in Mycobacterium kansasii is associated with rpoB mutation. Antimicrob. Agents Chemother. 45:2001;3056-3058.
30. Vogler A.J., Busch J.D., Percy-Fine S., Tipton-Hunton C., Smith K.L., Keim P. Molecular analysis of rifampicin resistance in Bacullus anthracis and Bacillus cereus. Antimicrob. Agents Chemother. 46:2002;511-513.
31. Fines M., Pronost S., Maillard K., Taouji S., LeClercq R. Characterization of mutations in the rpoB gene associated with rifampicin resistance in Rodococcus equi isolated from foals. J. Clin. Microbiol. 39:2001;2784-2787.
32. Neilsen K., Hindersson P., Hoiby N., Bangsborg J.M. Sequencing of the rpoB gene in Leionella pneumophila and characterization of mutations associated with rifampin resistance in the legionellaacaeae. Antimicrob. Agents Chemother. 44:2000;2679-2683.
33. Stefanelli P., Fazio C., La Rosa G., Marianelli C., Muscillo M., Mastrantonio P. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J. Antimicrob. Chemother. 47:2001;219-222.
34. Aubry-Damon H., Galinmand M., Gerbaud G., Courvalin P. rpoB mutation conferring rifampicin resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:2002;1571-1573.
35. Aubry-Damon H., Soussy C.J., Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:1998;2590-2594.
36. Heep M., Odenbreit S., Beck D., Decker J., Prohaska E., Rieger U., Lehn N. Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins. Antimicrob. Agents Chemother. 44:2000;1713-1715.
37. Cupples C.G., Cabrera M., Cruz C., Miller J.H. A set of lacZ mutations in Escherichia coli that allows rapid detection of specific frameshift mutations. Genetics. 125:1990;275-280.
38. J.H. Miller, A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor Press, Cold Spring Harbor, New York, 1992.
39. Miller J.H., Funchain P., Clendenin W., Huang T., Nguyen A., Wolff E., Yeung A., Chiang J.H., Garibyan L., Slupska M.M., Yang H. Escherichia coli strains (ndk) lacking nucleotide diphosphate kinase are powerful mutators for base substitutions and frameshifts in mismatch repair deficient strains. Genetics. 162:2002;5-13.
40. Michaels M.L., Cruz C., Grollman A.P., Miller J.H. Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7022-7025.
41. Drake J.W. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7160-7164.
42. W.J. Dixon, F.J. Massey Jr., Introduction to Statistical Analysis, McGraw-Hill, New York, 1969.
43. Leong P.M., Hsia H.C., Miller J.H. Analysis of spontaneous base substitutions generated in mismatch-repair deficient strains of Escherichia coli. J. Bacteriol. 168:1986;412-416.
44. Yanofsky C., Cox E.C., Horn V. The unusual mutagenic specificity of an E. coli mutator gene. Proc. Natl. Acad. Sci. U.S.A. 55:1966;274-281.
45. Miller J.H., Ganem D., Lu P., Schmitz A. Genetic studies of the lac repressor. I. Correlation of mutational sites with specific amino acid residues: construction of a collinear gene-protein map. J. Mol. Biol. 109:1977;275-301.
46. Miller J.H. Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182:1985;45-68.
47. Witkin E.M. UV mutagenesis and inducible DNA repair in Escherichia coli. Cold Spring Harbor Symp. Quant. Biol. 43:1978;881-886.
48. Brash D.E., Hazeltine W.A. UV-induced mutation hotspots occur at DNA damage hotspots. Nature. 298:1982;189-192.
49. Jones P.A. DNA methylation errors and cancer. Cancer Res. 56:1996;2463-2467.
50. Jones P., Taylor S., Mohandas T., Shapiro L. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc. Natl. Acad. Sci. U.S.A. 79:1982;1215-1219.
51. Broday L., Lee Y.W., Costa M. 5-azacytadine induces transgene silencing by DNA methylation in Chinese hamster cells. Mol. Cell Biol. 19:1999;3198-3204.
52. Levin D.E., Ames B.N. Classifying mutagens as to their specificity in causing the six possible transitions and transcersion: a simple assay using Salmonella mutagenicity assay. Environ. Mutagen. 8:1986;9-28.
53. Jackson-Grusby L., Laird P.W., Magge S.N., Moeller B.J., Jaenisch R. Mutagenicity of 5-aza- 2′ deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4681-4685.
54. Kelecsenyi Z., Spencer D.L., Caspary W.J. Molecular analysis of 5-azacytidine-induced variants in mammalian cells. Mutagenesis. 15:2000;25-31.
55. Higby D.J., Wallace H.J., Albert D.J., Holland J.F. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer. 33:1974;1219-1225.
56. Yarema K.J., Wilson J.M., Lippard S.J., Essigmann J.M. Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs. J. Mol. Biol. 236:1994;1034-1048.
57. Yarema K.J., Wilson J.M., Lippard S.J., Essigmann J.M. Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II). Nucl. Acids Res. 23:1995;4066-4072.
58. Brouwer J., van de Putte P., Fichtinger-Schepman A.M.J., Reedijk J. Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. U.S.A. 78:1981;7010-7014.
59. de Boer J.G., Glickman B.W. Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene. Carcinogenesis. 10:1989;1363-1367.
60. Nghiem Y., Cabrera M., Cupples C.G., Miller J.H. The mutY gene: a mutator locus in Escherichia coli that generates G:C → T:A transversions. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2709-2713.
61. Michaels M.L., Miller J.H. The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxyguanine). J. Bacteriol. 174:1992;6321-6325.
62. Maki H., Sekiguchi M. MutT protein specifically hydrolyzes a potent mutagenic substrate for DNA synthesis. Nature. 355:1992;273-275.
63. Schaaper R.M. Mechanisms of mutagenesis in the Escherichia coli mutator mutD5: role of DNA mismatch repair. Proc. Natl. Acad. Sci. U.S.A. 73:1988;5463-5467.
64. Kenyon C.J., Walker G.C. DNA-damaging agents stimulate gene expression at specific loci in Escherchia coli. Proc. Natl. Acad. Sci. U.S.A. 77:1980;2819-2823.
65. Wagner J., Gruz P., Kim S.R., Yamada M., Matsui K., Fuchs R.P.P., Nohmi T. The dinβ gene encodes a novel E. coli DNA polymerase, DNA pol IV, involved in mutagenesis. Mol. Cell. 4:1999;281-286.
66. Kim S.R., Matsui K., Yamada M., Gruz P., Nohmi T. Roles of chromosomal and episomal dinβ genes encoding DNA pol IV in targeted and untargeted mutagenesis in Escherichia coli. Mol. Genet. Genomics. 266:2001;207-215.
67. Strauss B.S., Roberts R., Francis L., Pouryazdanparast P. Role of the dinβ gene product in spontaneous mutation in Escherichia coli with an impaired replication polymerase. J. Bacteriol. 182:2000;6742-6750.
68. Kim S.R., Maenhaut-Michel G., Yamada M., Yamamoto Y., Matsui K., Sofuni T., Nohmi T., Ohmori H. Multiple pathways for SOS-induced mutagenesis in Escherichia coli: an overexpression of dinβ/dinP results in strongly enhancing mutagenesis in the absence of any exogenous treatment to damage DNA. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13792-13797.
69. Wagner J., Nohmi T. Escherichia coli DNA polymerase IV mutator activity: genetic requirements and mutational specificity. J. Bacteriol. 182:2000;4587-4595.